OSTERTAG ERIC (Chief Executive Officer) sold 160.70K shares of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $592.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/5/2022ACC: 0001209191-22-044562
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2020
-160.70K
Net shares
Net seller
$592.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
160.70K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−160.70K
Price / share
$3.69
Trade value
$592.81K
% of position
New position
8/3/2022
160.70K→0.00
Total
Net shares
−160.70K
Net value
-$592.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/3/2022 | S · Sale | −160.70K | $3.69 | $592.81K | New position | 160.70K | 0.00 |
| Total | −160.70K | -$592.81K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)5
Common Stock
IndirectShares owned3.66M
Common Stock
DirectShares owned695.97K
Common Stock
IndirectShares owned580.29K
Common Stock
IndirectShares owned3.36M
Common Stock
IndirectShares owned961.45K
Total
695.97K direct·8.56M indirect9.26M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.66M | Indirect |
| Common Stock | 695.97K | Direct |
| Common Stock | 580.29K | Indirect |
| Common Stock | 3.36M | Indirect |
| Common Stock | 961.45K | Indirect |
| Total | 9.26M | 695.97K direct·8.56M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported